Vietnam Medical Plastics Market Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

The Vietnam medical plastics market, worth USD 150 million, is expanding due to increasing healthcare needs, technological advancements, and demand for disposables like syringes and IV bags.

Region:Asia

Author(s):Dev

Product Code:KRAB1918

Pages:88

Published On:January 2026

About the Report

Base Year 2025

Vietnam Medical Plastics Market Overview

  • The Vietnam Medical Plastics Market is valued at USD 150 million, based on a five-year historical analysis. This growth is primarily driven by the increasing demand for medical devices, rising healthcare expenditures, and a growing aging population, as Vietnam’s medical device market has been expanding steadily. The market is also supported by advancements in medical technology, the rising prevalence of chronic diseases, and the growing use of lightweight, durable, and cost?effective polymers in single-use and implantable medical products.
  • Key regional hubs in this market include Ho Chi Minh City, Hanoi, and Da Nang, which dominate due to their robust healthcare infrastructure, concentration of hospitals and medical device manufacturers, and access to skilled labor. These cities, representing Southern, Northern, and Central Vietnam respectively, are also pivotal in research, manufacturing, and logistics for medical technology, supporting innovation and the adoption of advanced medical plastics across healthcare applications.
  • The management of medical devices, including those made from plastics, is governed by Decree No. 36/2016/ND-CP on management of medical devices issued by the Government of Vietnam, which has been amended and supplemented by Decree No. 169/2018/ND-CP and Decree No. 03/2020/ND-CP under the Ministry of Health. These instruments establish requirements for classification, registration, quality management systems, clinical evaluation, and post?marketing surveillance, thereby enhancing the quality and safety of medical devices and aligning domestic practices with international standards.
Vietnam Medical Plastics Market Size

Vietnam Medical Plastics Market Segmentation

By Material:The material segmentation of the market includes various types of plastics used in medical applications. The primary materials are Polyvinyl Chloride (PVC), Polypropylene (PP), Polyethylene (PE), Polystyrene (PS), Engineering Plastics (e.g., PC, PEEK, ABS), Silicones, and Others. Among these, PVC and PP are the most widely used due to their versatility, cost-effectiveness, ease of processing, and favorable properties for applications such as tubing, IV bags, syringes, and device housings.

Vietnam Medical Plastics Market segmentation by Material.

By Application:The application segmentation encompasses various uses of medical plastics in healthcare. Key applications include Disposables (syringes, IV bags, tubing, etc.), Drug Delivery Devices, Diagnostic Instruments, Catheters, Surgical Instruments and Components, and Others. The disposables segment is particularly dominant due to the increasing demand for single-use products in hospitals and clinics, driven by hygiene and safety concerns, infection control requirements, and alignment with international standards for sterile medical supplies.

Vietnam Medical Plastics Market segmentation by Application.

Vietnam Medical Plastics Market Competitive Landscape

The Vietnam Medical Plastics Market is characterized by a dynamic mix of regional and international players. Leading participants such as An Phat Holdings JSC, Rang Dong Plastic Joint Stock Company, Binh Minh Plastics JSC, Tien Phong Plastic JSC, Tan Dai Hung Plastic J.S. Co., Nhat Tan Plastic Manufacturing and Trading Co., Ltd., RKW Vietnam Co., Ltd., SCG Chemicals Vietnam Co., Ltd., Dow Vietnam LLC, BASF Vietnam Co., Ltd., Avient Vietnam Co., Ltd., Nhua Y Te (Medical Plastics) Vietnam JSC, CPI Vietnam Plastic Limited Company, Nghi Son Refinery and Petrochemical LLC (NSRP), and other emerging local medical plastic converters contribute to innovation, geographic expansion, and service delivery in this space, supported by growing demand for high-quality medical-grade resins and components.

An Phat Holdings JSC

2002

Hai Duong, Vietnam

Rang Dong Plastic Joint Stock Company

1961

Hanoi, Vietnam

Binh Minh Plastics JSC

1977

Ho Chi Minh City, Vietnam

Tien Phong Plastic JSC

1960

Hai Phong, Vietnam

Tan Dai Hung Plastic J.S. Co.

1999

Ho Chi Minh City, Vietnam

Company

Establishment Year

Headquarters

Revenue (USD, latest financial year)

3-year Revenue CAGR (%)

EBITDA Margin (%)

Return on Invested Capital (ROIC, %)

Market Share in Vietnam Medical Plastics (%)

Capacity Utilization Rate (%)

Vietnam Medical Plastics Market Industry Analysis

Growth Drivers

  • Increasing Demand for Medical Devices:The Vietnam medical device market is projected to reach $2.5 billion in future, driven by a growing population and rising healthcare needs. The demand for medical devices, including surgical instruments and diagnostic equipment, is expected to increase by 10% annually. This surge is fueled by the government's focus on enhancing healthcare services, which directly boosts the consumption of medical plastics used in these devices, thereby supporting market growth.
  • Advancements in Healthcare Infrastructure:Vietnam's healthcare expenditure is anticipated to reach $20 billion in future, reflecting a significant investment in healthcare infrastructure. The government is actively improving hospitals and clinics, which increases the demand for medical plastics in various applications. Enhanced healthcare facilities are expected to lead to a 15% rise in the usage of medical plastics, as they are essential for manufacturing medical devices and consumables, thus driving market expansion.
  • Rising Awareness of Hygiene and Safety:The COVID-19 pandemic has heightened awareness regarding hygiene and safety, leading to increased demand for disposable medical products. In future, the market for disposable medical devices is projected to grow to $1.8 billion, with a significant portion attributed to medical plastics. This trend is supported by the growing emphasis on infection control in healthcare settings, which drives the need for high-quality, safe medical plastic products.

Market Challenges

  • Stringent Regulatory Requirements:The medical plastics industry in Vietnam faces stringent regulatory requirements, which can hinder market growth. Compliance with international standards, such as ISO 13485, is mandatory for manufacturers. In future, the cost of compliance is estimated to reach $150 million, impacting smaller manufacturers disproportionately. These regulations, while essential for safety, can slow down product development and increase operational costs, posing a challenge to market players.
  • High Competition Among Manufacturers:The Vietnam medical plastics market is characterized by intense competition, with over 200 manufacturers vying for market share. This competitive landscape leads to price wars, which can erode profit margins. In future, the average profit margin for manufacturers is expected to decline to 8%, down from 12% in previous years. This challenge necessitates innovation and differentiation strategies to maintain profitability and market position.

Vietnam Medical Plastics Market Future Outlook

The Vietnam medical plastics market is poised for significant growth, driven by technological advancements and increasing healthcare investments. The integration of smart technologies in medical devices is expected to enhance product functionality and patient outcomes. Additionally, the shift towards sustainable materials will likely reshape the industry, as manufacturers seek to meet environmental standards. These trends indicate a dynamic market landscape, with opportunities for innovation and expansion in future.

Market Opportunities

  • Expansion of the Aging Population:Vietnam's aging population is projected to reach 20% in future, creating a substantial demand for medical devices tailored to elderly care. This demographic shift will drive the need for specialized medical plastics, presenting a lucrative opportunity for manufacturers to develop innovative products that cater to this growing segment.
  • Development of Biodegradable Plastics:The increasing focus on sustainability is driving interest in biodegradable medical plastics. With the Vietnamese government aiming to reduce plastic waste by 50% in future, there is a significant opportunity for companies to invest in R&D for biodegradable materials. This shift not only aligns with environmental goals but also meets consumer demand for eco-friendly products.

Scope of the Report

SegmentSub-Segments
By Material

Polyvinyl Chloride (PVC)

Polypropylene (PP)

Polyethylene (PE)

Polystyrene (PS)

Engineering Plastics (e.g., PC, PEEK, ABS)

Silicones

Others

By Application

Disposables (syringes, IV bags, tubing, etc.)

Drug Delivery Devices

Diagnostic Instruments

Catheters

Surgical Instruments and Components

Others

By End-Use Device Category

Single-use Medical Devices

Reusable Medical Devices

Medical Packaging and Containers

Implants and Prosthetics

Others

By Processing Technology

Injection Molding

Extrusion

Blow Molding

Thermoforming

D Printing / Additive Manufacturing

Others

By Material Properties

Biocompatible Plastics

Antimicrobial Plastics

High-Temperature and Sterilization-Resistant Plastics

Flexible and Elastomeric Plastics

Bio-based and Recyclable Plastics

Others

By Region

Northern Vietnam

Central Vietnam

Southern Vietnam

By Regulatory Compliance

ISO 13485 and related Quality Management Standards

CE Marking

FDA and other International Approvals

Local Ministry of Health Approvals

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Ministry of Health, Ministry of Industry and Trade)

Manufacturers and Producers of Medical Plastics

Distributors and Wholesalers of Medical Supplies

Healthcare Providers and Hospitals

Medical Device Companies

Industry Associations (e.g., Vietnam Plastics Association)

Financial Institutions and Banks

Players Mentioned in the Report:

An Phat Holdings JSC

Rang Dong Plastic Joint Stock Company

Binh Minh Plastics JSC

Tien Phong Plastic JSC

Tan Dai Hung Plastic J.S. Co.

Nhat Tan Plastic Manufacturing and Trading Co., Ltd.

RKW Vietnam Co., Ltd.

SCG Chemicals Vietnam Co., Ltd.

Dow Vietnam LLC

BASF Vietnam Co., Ltd.

Avient Vietnam Co., Ltd.

Nhua Y Te (Medical Plastics) Vietnam JSC

CPI Vietnam Plastic Limited Company

Nghi Son Refinery and Petrochemical LLC (NSRP)

Other Emerging Local Medical Plastic Converters

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Vietnam Medical Plastics Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Vietnam Medical Plastics Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Vietnam Medical Plastics Market Analysis

3.1 Growth Drivers

3.1.1 Increasing demand for medical devices
3.1.2 Advancements in healthcare infrastructure
3.1.3 Rising awareness of hygiene and safety
3.1.4 Government initiatives promoting healthcare

3.2 Market Challenges

3.2.1 Stringent regulatory requirements
3.2.2 High competition among manufacturers
3.2.3 Fluctuating raw material prices
3.2.4 Limited access to advanced technologies

3.3 Market Opportunities

3.3.1 Expansion of the aging population
3.3.2 Growth in medical tourism
3.3.3 Increasing investment in R&D
3.3.4 Development of biodegradable plastics

3.4 Market Trends

3.4.1 Shift towards sustainable materials
3.4.2 Integration of smart technologies in medical devices
3.4.3 Rise in telemedicine and remote healthcare
3.4.4 Customization of medical products

3.5 Government Regulation

3.5.1 Compliance with international standards
3.5.2 Implementation of safety protocols
3.5.3 Regulations on waste management
3.5.4 Incentives for local manufacturing

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Vietnam Medical Plastics Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Vietnam Medical Plastics Market Segmentation

8.1 By Material

8.1.1 Polyvinyl Chloride (PVC)
8.1.2 Polypropylene (PP)
8.1.3 Polyethylene (PE)
8.1.4 Polystyrene (PS)
8.1.5 Engineering Plastics (e.g., PC, PEEK, ABS)
8.1.6 Silicones
8.1.7 Others

8.2 By Application

8.2.1 Disposables (syringes, IV bags, tubing, etc.)
8.2.2 Drug Delivery Devices
8.2.3 Diagnostic Instruments
8.2.4 Catheters
8.2.5 Surgical Instruments and Components
8.2.6 Others

8.3 By End-Use Device Category

8.3.1 Single-use Medical Devices
8.3.2 Reusable Medical Devices
8.3.3 Medical Packaging and Containers
8.3.4 Implants and Prosthetics
8.3.5 Others

8.4 By Processing Technology

8.4.1 Injection Molding
8.4.2 Extrusion
8.4.3 Blow Molding
8.4.4 Thermoforming
8.4.5 3D Printing / Additive Manufacturing
8.4.6 Others

8.5 By Material Properties

8.5.1 Biocompatible Plastics
8.5.2 Antimicrobial Plastics
8.5.3 High-Temperature and Sterilization-Resistant Plastics
8.5.4 Flexible and Elastomeric Plastics
8.5.5 Bio-based and Recyclable Plastics
8.5.6 Others

8.6 By Region

8.6.1 Northern Vietnam
8.6.2 Central Vietnam
8.6.3 Southern Vietnam

8.7 By Regulatory Compliance

8.7.1 ISO 13485 and related Quality Management Standards
8.7.2 CE Marking
8.7.3 FDA and other International Approvals
8.7.4 Local Ministry of Health Approvals
8.7.5 Others

9. Vietnam Medical Plastics Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Revenue (USD, latest financial year)
9.2.3 3-year Revenue CAGR (%)
9.2.4 EBITDA Margin (%)
9.2.5 Return on Invested Capital (ROIC, %)
9.2.6 Market Share in Vietnam Medical Plastics (%)
9.2.7 Capacity Utilization Rate (%)
9.2.8 R&D Intensity (% of Revenue)
9.2.9 Capital Expenditure as % of Revenue
9.2.10 Export Revenue Share (%)
9.2.11 Average Selling Price Index (vs. market)
9.2.12 Customer Concentration (Top-5 share, %)
9.2.13 On-time Delivery Performance (%)
9.2.14 ESG / Sustainability Score (where available)

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 An Phat Holdings JSC
9.5.2 Rang Dong Plastic Joint Stock Company
9.5.3 Binh Minh Plastics JSC
9.5.4 Tien Phong Plastic JSC
9.5.5 Tan Dai Hung Plastic J.S. Co.
9.5.6 Nhat Tan Plastic Manufacturing and Trading Co., Ltd.
9.5.7 RKW Vietnam Co., Ltd.
9.5.8 SCG Chemicals Vietnam Co., Ltd.
9.5.9 Dow Vietnam LLC
9.5.10 BASF Vietnam Co., Ltd.
9.5.11 Avient Vietnam Co., Ltd.
9.5.12 Nhua Y Te (Medical Plastics) Vietnam JSC
9.5.13 CPI Vietnam Plastic Limited Company
9.5.14 Nghi Son Refinery and Petrochemical LLC (NSRP)
9.5.15 Other Emerging Local Medical Plastic Converters

10. Vietnam Medical Plastics Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Ministry of Health
10.1.2 Ministry of Industry and Trade
10.1.3 Ministry of Finance
10.1.4 Ministry of Planning and Investment

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Healthcare Facilities
10.2.2 Medical Equipment Suppliers

10.3 Pain Point Analysis by End-User Category

10.3.1 Hospitals
10.3.2 Clinics
10.3.3 Home Healthcare Providers

10.4 User Readiness for Adoption

10.4.1 Training and Support Needs
10.4.2 Technology Acceptance Levels

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Performance Metrics
10.5.2 Future Use Cases

11. Vietnam Medical Plastics Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Business Model Development


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail Strategies

3.2 Rural NGO Tie-ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service


7. Value Proposition

7.1 Sustainability Initiatives

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix
9.1.2 Pricing Band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 JV

10.2 Greenfield

10.3 M&A

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 JVs

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Activity Planning
15.2.2 Milestone Tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of industry reports from Vietnamese health authorities and medical associations
  • Review of published market studies and white papers on medical plastics
  • Examination of trade statistics and import/export data from government databases

Primary Research

  • Interviews with key opinion leaders in the medical device manufacturing sector
  • Surveys with procurement managers at hospitals and clinics
  • Field interviews with R&D heads at medical plastics companies

Validation & Triangulation

  • Cross-validation of findings through multiple data sources including trade publications
  • Triangulation of insights from primary interviews and secondary data analysis
  • Sanity checks conducted through expert panel discussions and feedback sessions

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of total market size based on healthcare expenditure trends in Vietnam
  • Segmentation of market by product type, including syringes, IV bags, and surgical instruments
  • Incorporation of government healthcare initiatives and policies promoting medical plastics

Bottom-up Modeling

  • Collection of sales data from leading medical plastics manufacturers in Vietnam
  • Estimation of production capacities and output volumes from local factories
  • Analysis of pricing strategies and cost structures of medical plastic products

Forecasting & Scenario Analysis

  • Multi-factor regression analysis incorporating demographic trends and healthcare access
  • Scenario modeling based on potential regulatory changes and technological advancements
  • Development of baseline, optimistic, and pessimistic market forecasts through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Hospital Procurement Departments90Procurement Managers, Supply Chain Coordinators
Medical Device Manufacturers70Product Development Managers, Quality Assurance Heads
Healthcare Regulatory Bodies40Regulatory Affairs Specialists, Compliance Officers
Research Institutions60Research Scientists, Academic Professors
End-users in Clinics80Clinic Managers, Medical Practitioners

Frequently Asked Questions

What is the current value of the Vietnam Medical Plastics Market?

The Vietnam Medical Plastics Market is valued at approximately USD 150 million, driven by increasing demand for medical devices, rising healthcare expenditures, and advancements in medical technology, particularly in single-use and implantable products.

What are the key materials used in the Vietnam Medical Plastics Market?

Which cities are the main hubs for the Vietnam Medical Plastics Market?

What are the main applications of medical plastics in Vietnam?

Other Regional/Country Reports

Philippines Medical Plastics Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030India Medical Plastics Market Outlook to 2030

Indonesia Medical Plastics Market

Malaysia Medical Plastics Market

KSA Medical Plastics Market

APAC Medical Plastics Market

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022